Cargando…

1411. Risks and Outcomes of Adenovirus Disease in Pediatric HSCT Recipients –Comparison of Current Antiviral Treatment Options

BACKGROUND: Adenovirus can cause multi-organ dysfunction in hematopoietic stem cell transplant recipients (SCTr). It accounts for 22% of infection-associated mortality in umbilical cord transplant recipients (UCTr). This study determines whether transplant characteristics are associated with risk of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Sanya J, Young, Rebecca R, Steinbach, William, Lugo, Debra J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776407/ http://dx.doi.org/10.1093/ofid/ofaa439.1593

Ejemplares similares

572. Antiviral Toxicities Among Pediatric Solid Organ Transplant Recipients
por: Downes, Kevin J, et al.
Publicado: (2020)

1075. Absolute Lymphocyte Count as a Predictor of Cytomegalovirus (CMV) Infection and Recurrence in Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Reekie, Joanne, et al.
Publicado: (2020)

P1411: DUAL EPIGENETIC AND GENETIC EDITING OF PRIMARY HUMAN HAEMATOPOIETIC STEM AND PROGENITOR CELLS
por: Saunderson, E., et al.
Publicado: (2022)

332. Phaeohyphomycosis Due to Scopulariopsis brumptii in a Hematopoietic Stem Cell Transplant (HSCT) Recipient
por: Syed, Sadia, et al.
Publicado: (2018)

Incidence and Outcomes of Cytomegalovirus (CMV) Infection among Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Furuno, Jon P, et al.
Publicado: (2017)

Prevention and management of human cytomegalovirus in pediatric HSCT recipients: A review
por: Hiskey, Lisa, et al.
Publicado: (2022)

1411. Missed HIV Clinic Visits among Youth Living with HIV in Alabama
por: Hao, Jiaying
Publicado: (2022)

The impact of viral respiratory infections in the first year post-transplant period of pediatric hematopoietic stem cell transplant (HSCT) recipients
por: Piralla, Antonio, et al.
Publicado: (2016)

Immunogenicity of Inactivated Varicella Zoster Vaccine (ZV(IN)) in Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Recipients
por: Boeckh, Michael, et al.
Publicado: (2017)

P1346: EVALUATION OF CURRENT NATIONAL PRACTICE IN THE PREVENTION OF PTLD POST PAEDIATRIC HSCT
por: Kissane, E., et al.
Publicado: (2022)

926. Risk factors for post-letermovir cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell transplant (HSCT) recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

1411. Noninvasive Assessment of Intralesional Antimicrobial Concentration-Time Profiles in Pulmonary and Central Nervous System Tuberculosis using Dynamic (18)F-Pretomanid Positron Emission Tomography
por: Mota, Filipa, et al.
Publicado: (2021)

1762. Genotype Prevalence and Molecular Characteristics of Human Adenovirus in Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Blumenstock, Jesse, et al.
Publicado: (2019)

1411. Differentiation of Fungal Abscess of Brain From Brain Glioblastoma by MRI Scan ADC Value
por: Aziz, Kashif, et al.
Publicado: (2019)

1411. Operating room air may harbor pathogens: the role of an ultraviolet air filtration unit
por: Fernández-Rodríguez, Diana, et al.
Publicado: (2023)

452 Pseudo-Outbreak of Fulminant Toxoplasmosis in Hematopoietic Stem Cell Transplant [HSCT] Recipients
por: Isa, Flonza, et al.
Publicado: (2014)

1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT)
por: Kokogho, Afoke, et al.
Publicado: (2022)

Continuous non-invasive monitoring of the skin temperature of HSCT recipients
por: van Vliet, Maarten, et al.
Publicado: (2009)

Biological and Genetic Aspects of Donor-Recipient Matching in HSCT
por: Lange, Andrzej, et al.
Publicado: (2012)

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients
por: Machado, Clarisse MARTINS, et al.
Publicado: (2020)

Fusarium infection manifesting as toe cellulitis in HSCT recipient
por: Malkiel, Sarah, et al.
Publicado: (2022)

174. Shotgun Metagenomics and Colonization by Antibiotic-resistant Bacteria in Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Heston, Sarah M, et al.
Publicado: (2020)

1563. Relationship of Cumulative Viral Burden of Adenovirus with Mortality in Allogeneic Hematopoietic Cell Transplant Recipients with Early Adenovirus Viremia
por: Lee, Yeon Joo, et al.
Publicado: (2018)

Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
por: Ohmoto, Akihiro, et al.
Publicado: (2022)

Bioactivity of 2′-deoxyinosine-incorporated aptamer AS1411
por: Fan, Xinmeng, et al.
Publicado: (2016)

Anabaenopeptins from Nostoc edaphicum CCNP1411
por: Konkel, Robert, et al.
Publicado: (2022)

Insights into the binding mode of AS1411 aptamer to nucleolin
por: Bie, Lihua, et al.
Publicado: (2022)

Anti-nucleolin aptamer AS1411: an advancing therapeutic
por: Van den Avont, Alexander, et al.
Publicado: (2023)

Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets
por: Murphy, Emily M., et al.
Publicado: (2020)

Title: Measuring quality of life among recipients of opioid agonist treatment-current update
por: Piyali, Mandal, et al.
Publicado: (2022)

874. Pseudo-outbreak of Adenovirus in Bronchoscopy Suite
por: Seidelman, Jessica L, et al.
Publicado: (2020)

Fulminant isolated adenovirus hepatitis 5 months after haplo-identical HSCT for AML
por: Detrait, Marie, et al.
Publicado: (2015)

What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis
por: Fucile, Carmen, et al.
Publicado: (2018)

Risk factors for healthcare-associated Clostridium difficile infection in pediatric hematopoietic stem cell transplant recipients
por: Drew, Richard H, et al.
Publicado: (2017)

Evusheld™ Pre-Exposure COVID-19 Prophylaxis in Pediatric Hematopoietic Stem Cell Transplant (HSCT) and Cellular Therapy Recipients: A Single Institution Retrospective Series
por: DePriest, Brittany Paige, et al.
Publicado: (2023)

P1326: FACTORS ASSOCIATED WITH THE OUTCOME OF ALLO-HSCT FOR ADVERSE-CYTOGENETIC RISK ACUTE MYELOID LEUKEMIA
por: Cerezo-Martin, J. M., et al.
Publicado: (2022)

AS1411-functionalized delivery nanosystems for targeted cancer therapy
por: Kozani, Pooria Safarzadeh, et al.
Publicado: (2021)

1188. Could Chlorehexidine (CHX) Bathing Decrease the Incidence of Carbapenem-Resistant Enterobacteria (CRE) Bacteremia in Previously Colonized CRE Hematopoietic Stem Cell Transplant Recipients (HSCT)?
por: Velez, Juan Diego, et al.
Publicado: (2018)

1438. Latent tuberculosis infection (LTBI) in hematopoietic stem cell transplantation (HSCT) recipients: a retrospective Italian cohort study in Tor Vergata University Hospital, Rome.
por: Compagno, Mirko, et al.
Publicado: (2022)

1084. Epidemiology and Long-term Outcomes of Cytomegalovirus (CMV) in Pediatric Liver Transplant Recipients (PLTR) at Texas Children’s Hospital (TCH)
por: Deray, Kristen Valencia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cadp8ugnhcdco9of0pp5n2506a